Search research articles
Contact Us
Filters
Showing results (81-90 of 171) with videos related to
Page
of 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant
A R Martin, A D Carides, J D Pearson, et al.
JAMA Oncology
|
September 18, 2015
First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial
Sant P Chawla, Zsuzsanna Papai, Guzel Mukhametshina, et al.
Clinical Colorectal Cancer
|
November 26, 2002
Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil
A J Bilchik, T F Wood, S P Chawla, et al.
Anticancer Research
|
May 29, 2023
Early-stage <i>CCNG1</i>+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a <i>CCNG1</i> Inhibitor
Sant P Chawla, Olga Olevsky, Geeta Iyengar, et al.
Cancer
|
June 1, 1989
Recovery of sperm production after chemotherapy for osteosarcoma
M L Meistrich, S P Chawla, M F Da Cunha, et al.
Radiology
|
March 1, 1989
Osteosarcoma: angiographic assessment of response to preoperative chemotherapy
C H Carrasco, C Charnsangavej, A K Raymond, et al.
Journal of Graduate Medical Education
|
July 4, 2015
Transforming Ward Rounds Through Rounding-in-Flow
Alvin S Calderon, C Craig Blackmore, Barbara L Williams, et al.
Frontiers in Immunology
|
March 15, 2024
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers
Richard T Kenney, John K Cini, Susan Dexter, et al.
Oncology
|
June 1, 2011
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma
Kristen N Ganjoo, Lee D Cranmer, James E Butrynski, et al.
Frontiers in Molecular Medicine
|
August 1, 2024
Three year results of Blessed: Expanded access for DeltaRex-G for an intermediate size population with advanced pancreatic cancer and sarcoma (NCT04091295) and individual patient use of DeltaRex-G for solid malignancies (IND# 19130)
Sant P Chawla, Steven Wong, Doris Quon, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 171) with videos related to
Sort By:
Page
of 18
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant
A R Martin, A D Carides, J D Pearson, et al.
JAMA Oncology
|
September 18, 2015
First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial
Sant P Chawla, Zsuzsanna Papai, Guzel Mukhametshina, et al.
Clinical Colorectal Cancer
|
November 26, 2002
Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil
A J Bilchik, T F Wood, S P Chawla, et al.
Anticancer Research
|
May 29, 2023
Early-stage <i>CCNG1</i>+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a <i>CCNG1</i> Inhibitor
Sant P Chawla, Olga Olevsky, Geeta Iyengar, et al.
Cancer
|
June 1, 1989
Recovery of sperm production after chemotherapy for osteosarcoma
M L Meistrich, S P Chawla, M F Da Cunha, et al.
Radiology
|
March 1, 1989
Osteosarcoma: angiographic assessment of response to preoperative chemotherapy
C H Carrasco, C Charnsangavej, A K Raymond, et al.
Journal of Graduate Medical Education
|
July 4, 2015
Transforming Ward Rounds Through Rounding-in-Flow
Alvin S Calderon, C Craig Blackmore, Barbara L Williams, et al.
Frontiers in Immunology
|
March 15, 2024
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers
Richard T Kenney, John K Cini, Susan Dexter, et al.
Oncology
|
June 1, 2011
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma
Kristen N Ganjoo, Lee D Cranmer, James E Butrynski, et al.
Frontiers in Molecular Medicine
|
August 1, 2024
Three year results of Blessed: Expanded access for DeltaRex-G for an intermediate size population with advanced pancreatic cancer and sarcoma (NCT04091295) and individual patient use of DeltaRex-G for solid malignancies (IND# 19130)
Sant P Chawla, Steven Wong, Doris Quon, et al.
Page
of 18